
Sign up to save your podcasts
Or


In part one of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss recent clinical trials on exenatide as a disease-modifying therapy for Parkinson disease.
Show reference:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract
By American Academy of Neurology4.8
129129 ratings
In part one of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss recent clinical trials on exenatide as a disease-modifying therapy for Parkinson disease.
Show reference:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract

496 Listeners

295 Listeners

51 Listeners

288 Listeners

3,342 Listeners

258 Listeners

13 Listeners

21 Listeners

194 Listeners

511 Listeners

365 Listeners

6,355 Listeners

180 Listeners

370 Listeners

79 Listeners